|
Market Closed -
Nasdaq
16:30:00 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 3.125 USD | +0.81% |
|
-2.95% | -75.49% |
| 10-28 | Scienture Holdings, Inc. - Shareholder/Analyst Call | |
| 10-13 | Scienture Holdings, Inc. Reports Preliminary, Unaudited Revenue Results for the Third Quarter Ended September 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Pharmaceuticals Wholesale
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 5.13M | - | - | - | ||
| 1,206B | |||||
| 665B | |||||
| 515B | |||||
| 381B | |||||
| 362B |
Select your edition
All financial news and data tailored to specific country editions
